Drafts comprehensive Quality Agreements for pharmaceutical contract manufacturing to ensure cGMP and FDA compliance.
This skill automates the creation of enforceable Quality Agreements between product owners and Contract Manufacturing Organizations (CMOs). It systematically structures roles and responsibilities according to FDA 21 CFR 210/211 and ICH Q7 guidelines, covering critical aspects like batch disposition, multi-tier change control workflows, audit rights, and notification timelines. By integrating regulatory identifiers and site-specific data, it ensures that technical quality requirements are clearly defined and legally independent from commercial supply terms.
Características Principales
01Defines mandatory notification timelines for critical and routine quality events
02Generates detailed Quality Unit responsibility matrices for owners and CMOs
03Incorporates specific FDA 2016 and 2018 guidance on contract manufacturing and data integrity
042 GitHub stars
05Drafts comprehensive audit protocols including routine, for-cause, and unannounced rights
06Establishes a three-tier change control framework (Minor, Major, Emergency)
Casos de Uso
01Establishing quality terms when onboarding a new CMO for drug product manufacturing
02Updating existing legacy agreements to align with modern FDA data integrity standards
03Drafting specific quality appendices for master supply agreements in the biotech sector